Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Peak Rx #2
AddedMar 20, 2024
UpdatedJun 18, 2026
Peak Rx #2

Peak Rx #2

Seed

Peak Rx #2 provides pharmaceutical healthcare services since 2013 from Castle Rock, Colorado.

HQ
Castle Rock, CO, US
Founded
2013
Overview
Compare
Fundraising
Employees

Peak Rx #2 operates in the healthcare industry and focuses on pharmaceutical services.

The company was founded in 2013 and is headquartered in Castle Rock, Colorado.

Peak Rx #2 - Similar Companies

Pctrx logo

Pctrx

Citizens Rx logo

Citizens Rx

Creegh Pharmaceuticals logo

Creegh Pharmaceuticals

Healthvest Craig Ranch logo

Healthvest Craig Ranch

Caring Pharmacy logo

Caring Pharmacy

Healthscripts Of America logo

Healthscripts Of America

VendRx logo

VendRx

PleoPharma logo

PleoPharma

pleopharma.com

PharmRight logo

PharmRight

GeniusRx logo

GeniusRx

geniusrx.com

Vertice Pharma logo

Vertice Pharma

NuScriptRx logo

NuScriptRx

nuscriptrx.com

Leading Pharma logo

Leading Pharma

leadingpharma.com

Pharma Solutions logo

Pharma Solutions

pharma.solutions

Medsbyme logo

Medsbyme

Peak Rx #2 - Quick Facts

Who are Peak Rx #2's competitors?

Companies similar to Peak Rx #2 include Pctrx, Citizens Rx, Creegh Pharmaceuticals and Healthvest Craig Ranch.

When was Peak Rx #2 founded?

Peak Rx #2 was founded in 2013.

Where is Peak Rx #2's headquarters located?

Peak Rx #2's headquarters is located in Castle Rock, CO, US.

When was Peak Rx #2's last funding round?

Peak Rx #2's most recent funding round was for $400k (USD) in March 2014.

How much has Peak Rx #2 raised to-date?

As of Mar 14, 2014, Peak Rx #2 has raised a total of $400k (USD).

How many employees does Peak Rx #2 have?

Peak Rx #2 has 50 employees as of Feb 5, 2024.

Peak Rx #2 - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Healthcare
  • Pharmaceuticals
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 11 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified